10/06/2021 (Agence Europe) – On Thursday 10 June, the European Parliament opposed the European Commission’s plan to extend the authorisation in the EU of some 40 toxic active substances, including flumioxazin, a substance classified as a category 1B reproductive toxicant and suspected since 2014 of causing potential disruption of the endocrine system (see EUROPE B12736A6). The objection to the European Commission implementing regulation (EU) 2021/745 of 6 May 2021 amending implementing...